Head of NCPA to step down
ALEXANDRIA, Va. Bruce Roberts will step down as EVP and CEO of the National Community Pharmacists Association this summer, the NCPA announced Wednesday.
Roberts, who has served as the head of the group for eight years, said he would step down on June 25.
“After nearly nine years at the helm of NCPA, the time seems right to turn over the reins of the association,” Roberts said in a statement. “I’m proud to have led a team that has done so much to position community pharmacy in a more favorable light in our healthcare system. The stronger voice we’ve developed for NCPA in the political arena is producing policies that help local pharmacists continue to care for their patients. With NCPA on solid footing and well positioned to do great things in the coming years, I have decided it’s time for me to move on to the next chapter.”
SVP and COO B. Douglas Hoey has been designated to serve as acting EVP and CEO after Roberts leaves and until a replacement is found. Roberts will go on to become president and CEO of BeneCard PBF, a “prescription benefit facilitator” that bills itself as an alternative to the traditional pharmacy benefit manager model.
“Bruce Roberts’ vision and passion for independent community pharmacy have greatly benefited NCPA members, and his service has been deeply appreciated,” NCPA president Joseph Harmison said. “Bruce helped NCPA develop into both an extremely effective advocate for community pharmacists as well as a source of market-oriented solutions to support our members.”
Hooper Holmes launches Diabetes Know Now!
BASKING RIDGE, N.J. Hooper Holmes announced a new, interactive health-screening platform that can efficiently identify people with undiagnosed diabetes or prediabetes.
Diabetes Know Now! is an innovative “screen before the screen” that combines an online diabetes risk assessment with an at-home diabetes laboratory test. Users complete an online diabetes risk assessment that places them in three risk categories — high, moderate or low. Users at high risk for having or developing diabetes then are offered an at-home test kit that allows them to collect their own blood sample and return it to Hooper Holmes’ Heritage Labs. Heritage Labs then completes a Hemoglobin A1c test, which the American Diabetes Association now recommends as the screening test for diabetes, and returns the results electronically to the secure Diabetes Know Now! account established by the user.
To commemorate the launch, Hooper Holmes made Diabetes Know Now! available to its employees in line with Diabetes Alert Day.
“Prior to Diabetes Know Now! there was not an effective and efficient way to target diabetes screenings,” said Chris Behling, president of Hooper Holmes health and wellness. “Now, instead of having to complete blood tests on an entire population, we can improve the efficiency and effectiveness of our customers’ programs, by only needing to complete blood testing on a targeted group who are at the highest risk for having or developing diabetes.”
Biogen Idec names billionaire as board member
CAMBRIDGE, Mass. Biogen Idec appointed a nominee of billionaire investor Carl Icahn to its board Monday, the Swiss drug maker announced.
Biogen Idec appointed Icahn Partners nominee Eric Rowinsky and Stephen Sherwin, selected by the company as part of its effort to find new directors, to its board of directors.
On the same day, Bloomberg quoted Icahn as saying that he would like to see Biogen Idec sold to a larger drug maker, on account of its pipeline, and also split into two business units, one for neurology and one for cancer.